Vijaya Diagnostic Centre Limited has informed the Exchange that Board of Directors at its meeting held on May 07, 2026, recommended Final Dividend of Rs. 2 per equity share.
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.4 pts more than Nifty Smallcap 250 and 4.1 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vijaya Diagnostic Centre's Board recommended a final dividend of ₹2 per equity share (200% on face value of ₹1/-) for FY2026, subject to shareholder approval at the upcoming AGM. The company also granted 1,79,500 Employee Stock Options (ESOPs) at ₹784 per option to eligible employees under the VDCL Employee Stock Option Plan 2018. Additionally, the Board approved acquisition of MRI, EEG and NCV Services Business from Medinova Millennium MRI Services LLP (a wholly-owned subsidiary) for approximately ₹4.20 crore, expected to complete within 3 months. Independent Director Dr. D Nageshwar Reddy will not seek re-appointment for a second term effective May 25, 2026 due to other professional commitments.
The 200% dividend payout signals strong cash generation and rewards shareholders. The ESOP grant aligns employee and management interests with long-term growth. The business acquisition from the WOS streamlines operations within the parent company.